Clinical and experimental studies have implicated high circulating levels of the cytokine tumour necrosis factor-α (TNF-α) in the pathogenesis of insulin resistance, not only in obesity and diabetes, but also in clinical conditions associated with cachexia and sepsis. TNF-α impairs insulin-mediated glucose uptake in adipocytes, but because of lipolytic effects the interpretation of clinical studies and the extent to which TNF-α affects muscle insulin sensitivity are unclear. In addition, protein kinase C (PKC) has recently been implicated in the mechanism of TNF-α-induced insulin resistance. The present study investigated the effects of TNF-α and a PKC inhibitor (RO-318220) on basal and insulin-stimulated 2-[3H]deoxyglucose uptake in cultured L6 myoblasts. Reverse transcriptase–PCR analysis confirmed that L6 myoblasts express TNF-α receptors I and II (p60 and p80). Dose–response curves for glucose uptake were fitted to a quadratic function to derive CI-150 values (concentration of insulin required to increase glucose uptake by 50%). Incubation with TNF-α at 1 or 10 ng/ml for 24 h had no significant effect on basal glucose uptake, insulin sensitivity or maximal insulin responsiveness. CI-150 values (means±S.E.M.) were as follows: basal, 91.2±13 nM; 1 ng/ml TNF-α, 102±12 nM; and basal, 70.8±13 nM; 10 ng/ml TNF-α, 43.7±40 nM. PKC inhibition markedly attenuated glucose uptake, but there was no difference in insulin sensitivity with RO-318220 alone compared with RO-318220+TNF-α. In conclusion, although increased TNF-α expression and plasma concentrations have been implicated in the pathogenesis of insulin resistance in various clinical states, there is no evidence that TNF-α impairs insulin-stimulated glucose uptake in a skeletal-muscle-derived cell line.
Skip Nav Destination
Article navigation
Research Article|
August 31 2000
Effects of tumour necrosis factor-α and inhibition of protein kinase C on glucose uptake in L6 myoblasts Available to Purchase
Divina PATIAG;
Divina PATIAG
1School of Medical and Surgical Sciences, Division of Vascular Medicine, University of Nottingham, U.K.
Search for other works by this author on:
Samuel GRAY;
Samuel GRAY
1School of Medical and Surgical Sciences, Division of Vascular Medicine, University of Nottingham, U.K.
Search for other works by this author on:
Iskander IDRIS;
Iskander IDRIS
1School of Medical and Surgical Sciences, Division of Vascular Medicine, University of Nottingham, U.K.
Search for other works by this author on:
Richard DONNELLY
1School of Medical and Surgical Sciences, Division of Vascular Medicine, University of Nottingham, U.K.
Correspondence: Professor Richard Donnelly, Division of Vascular Medicine, University of Nottingham, Derbyshire Royal Infirmary, Derby DE1 2QY, U.K. (e-mail [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
February 14 2000
Revision Received:
May 30 2000
Accepted:
June 13 2000
Online ISSN: 1470-8736
Print ISSN: 0143-5221
The Biochemical Society and the Medical Research Society © 2000
2000
Clin Sci (Lond) (2000) 99 (4): 303–307.
Article history
Received:
February 14 2000
Revision Received:
May 30 2000
Accepted:
June 13 2000
Citation
Divina PATIAG, Samuel GRAY, Iskander IDRIS, Richard DONNELLY; Effects of tumour necrosis factor-α and inhibition of protein kinase C on glucose uptake in L6 myoblasts. Clin Sci (Lond) 1 October 2000; 99 (4): 303–307. doi: https://doi.org/10.1042/cs0990303
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |